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InﬂammationMacrophages are one of the most abundant leucocytes in the intestinal mucosa where they are essential
for maintaining homeostasis. However, they are also implicated in the pathogenesis of disorders such as
inﬂammatory bowel disease (IBD), offering potential targets for novel therapies. Here we discuss the
function of intestinal monocytes and macrophages during homeostasis and describe how these popula-
tions and their functions change during infection and inﬂammation. Furthermore, we review the current
evidence that the intestinal macrophage pool requires continual renewal from circulating blood
monocytes, unlike most other tissue macrophages which appear to derive from primitive precursors that
subsequently self-renew.
 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
The intestine encounters more antigen than any other part of
the body and therefore it is no surprise that it is home to the larg-
est compartment of the immune system. Mononuclear phagocytes
(MPs), including both dendritic cells (DC) and macrophages (m/),
play a central role in discriminating harmful from harmless anti-
gens. They initiate and sustain protective immune responses
mounted towards pathogenic organisms, but also ensure that local
and systemic tolerance is generated in response to innocuous anti-
gens. When tolerance against dietary proteins and the resident
commensal microbiota breaks down, this can lead to chronic
inﬂammatory disorders such as coeliac disease and Crohn’s dis-
ease; MPs are also implicated in these processes [1]. Understand-
ing whether these somewhat paradoxical roles are carried out by
the same MP, or if independent, functionally distinct subsets of
MP exist is important for the development of new therapies for
the treatment of inﬂammatory bowel disease (IBD) and other
conditions.
In this review, we will discuss how intestinal macrophages
(m/) contribute to these processes, highlighting how they
develop from classical monocytes and showing how their func-
tion and fate alters depending on the presence or absence of
inﬂammation.2. Mononuclear phagocyte heterogeneity in the intestine
Deﬁning the nature and origins of individual subsets of intesti-
nal MPs has been complicated by the fact that functionally distinct
populations have overlapping phenotypes. For instance, although
DC are identiﬁed traditionally by their expression of CD11c and
MHCII, it is now clear that multiple cell types express CD11c in
the mucosa, including m/ and eosinophils [2]. Furthermore, resi-
dent gut m/ express high levels of MHCII [3–5], meaning that a pa-
nel of different markers is needed to discriminate these cells
properly (see below). The importance of identifying these cells pre-
cisely is underlined by the fact that DC and m/ fulﬁl quite distinct
functions in intestinal immune responses. By deﬁnition, DCs mi-
grate constitutively in a CCR7-dependent manner to the draining
lymph node, where they interact with and cause differentiation
of recirculating naïve T cells. On the other hand, m/ are sessile, tis-
sue resident cells whose principal role is to clear and degrade deb-
ris or pathogens, with little or no ability to prime naïve T cells [6].
Recent work from ourselves and others has shown that a com-
bination of surface markers is needed to tease apart DC and m/
amongst the MP populations found in normal intestinal lamina
propria (LP) (see Table 1). F4/80 and CD64 (the high afﬁnity FcRc1)
are particularly useful in this respect, as CD11c+MHCII+ MPs
expressing these markers have been shown to be resident m/, with
high phagocytic activity, little ability to prime naïve T cells and
being absent from intestinal lymph [6–9]. In contrast, CD11c+-
MHCII+ MPs that lack expression of F4/80 and CD64 are found in
afferent lymph, prime naïve T cells and are non-phagocytic [7–9].
Their identity as bona ﬁde DC is conﬁrmed by their expression of
the DC-speciﬁc transcription factor Zbtb46 and their dependence
Table 1
Surface marker expression by monocytes, macrophages and dendritic cells in the
intestinal mucosa.
Newly extravasated
monocytes
Mature
macrophages
Dendritic
cells
CD11b + + +/*
CD11c  ++ +++
CD14 + ++ 
CD64 Low +++ 
CD103   +/*
CD172a + + +/*
F4/80 Low +++ 
MHCII  +++ +++
Ly6C +++  
CX3CR1 ++ +++ +/*
* These markers deﬁne functionally distinct dendritic cell subsets with speciﬁc
transcription factor requirements.
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m/ [6,9,10]. The migratory F4/80/CD64- MPs can be further subdi-
vided into four subsets on the basis of CD103 and CD11b expres-
sion, with each subset displaying functional specialisation in
terms of T cell polarisation [9] (reviewed in [11]). Importantly,
these studies also show that CD103 expression alone cannot be
used to distinguish DC from m/, as has sometimes been assumed.
Similar cautions must be applied to the interpretation of CX3CR1
expression. Although it is now clear that all intestinal MPs express-
ing high levels of CX3CR1 are F4/80+CD64+ m/ and most mature
intestinal m/ are CX3CR1hi, intermediate levels of CX3CR1
(CX3CR1int) can be found on cells of both the DC and m/ lineage
[6,7,9], emphasising the need for additional markers in distinguish-
ing these cell types (see Table 1).3. Functions of macrophages in the steady state mucosa
The primary function of intestinal m/ is to act as effector cells
of the innate immune system. Their close association with the epi-
thelial monolayer, coupled with their high phagocytic and bacteri-
cidal activity, means they are ideally positioned to capture and
destroy any material breaching the epithelial barrier. They may
also be involved in clearing effete epithelial cells [12] and in tissue
remodelling [13]. However, unlike m/ in other tissues, ingestion of
bacteria or exposure to stimuli such as TLR ligands does not trigger
pro-inﬂammatory responses by mucosal m/, which display
remarkable anergy to such stimulation [7,14]. Despite being avidly
phagocytic, they also lack respiratory burst activity [15] or gener-
ation of nitric oxide [16]. Nevertheless, these cells are not com-
pletely inert and indeed, they show features of having been
activated by their local environment, including high levels of
MHCII expression, constitutive production of TNFa and a foamy,
vacuolated cytoplasm [7,17–19]. Intestinal m/ also play an active
role in maintaining the integrity of the epithelial barrier through
the production of prostaglandin E2, which promotes the prolifera-
tion and survival of epithelial progenitors [20]. Thus, they appear
to exist in a balanced state in which partial activation has occurred,
but inﬂammation is prevented.4. Intestinal macrophages and adaptive immunity
CX3CR1hi m/ in LP take up orally administered protein antigens
efﬁciently [21] and because of their expression of high levels of
MHCII, intestinal m/ are frequently included amongst the ‘‘antigen
presenting cells’’ (APC) of the mucosa [22]. Indeed it has been pro-
posed that they play a speciﬁc role in driving the differentiation of
antigen-speciﬁc FoxP3+ regulatory T cells (Treg) from naïve CD4+ Tcells in the intestine [23] and anatomical differences in the num-
bers of Treg in different parts of the intestine correlate with the
numbers of m/ [24]. However under steady state conditions, intes-
tinal m/ cannot activate naïve CD4+ T cells in vitro and do not mi-
grate to the MLN [6]; furthermore naïve CD4+ T cells are essentially
absent from the normal mucosa [25]. Thus it is unlikely that m/
can be involved in the initial priming of Treg. Instead IL10 produc-
tion by gut resident m/ may facilitate the secondary expansion
and maintenance of FoxP3+ Treg that have migrated there after ini-
tial priming in the MLN [26,27]. Intestinal m/ may play a similar
role in the maintenance of other types of mucosal T cells, with mic-
robiota-driven production of IL1b by mucosal m/ having been
shown to assist the development of Th17 cells [28]. Whether these
processes require cognate interactions between antigen speciﬁc
T cells and m/ in vivo remains to be determined.5. Origins of steady state intestinal macrophages
5.1. Circulating monocytes and tissue macrophage homeostasis
The traditional view of the mononuclear phagocyte system
(MPS) is that monocyte precursors develop in the bone marrow
(BM), with mature monocytes then entering the circulation and
migrating into the organs of the body to replenish tissue macro-
phages [29]. In mice, monocytes arise from the common macro-
phage and dendritic cell progenitor (MDP) [30,31] through a
common monocyte progenitor (cMoP) [32]. They express the
CSF1R (CD115) and two subsets can be identiﬁed on the basis of
Ly6C (or Gr-1) expression [33]. The larger subset is Ly6Chi (Gr-1+)
and expresses high levels of CCR2 and CD62L, but low levels of
CX3CR1 [33]. Although these Ly6Chi monocytes were originally
termed ‘‘inﬂammatory’’, given their readiness to enter inﬂamed tis-
sues, they are now referred to as ‘classical’ monocytes [34]. Ly6Chi
monocyte egress from the BM is dependent on the CCR2 chemo-
kine receptor and mice deﬁcient in CCL2 or CCR2 have essentially
no circulating monocytes, as well as showing defective recruitment
of m/ during inﬂammation [35,36]. The smaller subset of Ly6Clo-
CX3CR1+ monocytes expresses lower levels of CCR2 and CD62L
and was originally proposed to be a distinct lineage of monocytes
that replenished steady state macrophage populations [33]. How-
ever current evidence indicates that Ly6Clo monocytes are the
progeny of CSF-1 dependent maturation of Ly6Chi monocytes and
they have little or no ability to emigrate from the bloodstream into
tissues [37,38]. As such, their primary function is now believed to
be in the maintenance of the vasculature, including the disposal of
apoptotic endothelial cells through the recruitment of neutrophils
[39,40]; they are now referred to as ‘patrolling’ or ‘non-classical’
monocytes [34].
Human CD115+ monocytes have also been segregated into
subsets based on their expression of the LPS co-receptor CD14
and CD16 (FccRIII) [41]. Whereas CD14hi CD16 monocytes ex-
press CCR2 and are the equivalent of classical Ly6Chi murine
monocytes, CD14loCD16+ monocytes lack CCR2 expression and
are homologous to non-classical monocytes [34]. As in mice, the
human monocyte subsets appear to be related to each another
developmentally, with CD14hiCD16- monocytes maturing into
CD14loCD16+ ‘non-classical’ monocytes through a CD14+CD16+
intermediary. Gene expression analysis has revealed that there
is a high degree of conservation between the homologous subsets
in mouse and man [42].5.2. Generation of tissue macrophages from foetal precursors
More recently, it has been suggested that blood monocytes play
little or no role in the homeostasis of resident tissue m/. Rather, it
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yolk sac (YS) and/or foetal liver (FL) that seed tissues during
embryonic development and are then maintained in adult life by
self-renewal in situ. Using a variety of lineage tracking techniques
and cell kinetic approaches, this process has been shown to be the
origin of microglia in the central nervous system (CNS) [38,43,44],
liver Kupffer cells [38,44], lung alveolar m/ [38,45], m/ of the per-
itoneal cavity [46] and Langerhans cells in the epidermis of the skin
[38,44,47,48]. By extension, it is often assumed that similar mech-
anisms apply to m/ in all other healthy tissues [49]. However our
recent work indicates that the intestinal m/ pool is an exception to
this hypothesis, by requiring continuous replenishment by blood
Ly6Chi monocytes [7]. Varol and colleagues were the ﬁrst to show
that classical Ly6Chi monocytes could give rise to CD103CD11b+-
CX3CR1+ MP in the mucosa of myeloid cell depleted hosts and this
was conﬁrmed by subsequent work [22,50,51]. Although the cells
derived from Ly6Chi monocytes were initially considered to be
CD103 DC, it is now clear that most actually belong to the m/
lineage and more recently, it has been shown directly that Ly6Chi
monocytes give rise to F4/80+ CD64+ CX3CR1hi resident m/ in stea-
dy state intestine [7,8].
The recruitment of Ly6Chi monocytes to the adult mucosa is
dependent on CCR2, as mice lacking either CCR2 or its ligand
CCL2 have markedly reduced intestinal m/ pools [7,52]. That this
active recruitment needs to continue throughout life is shown by
the fact that acute interruption of the CCL2-CCR2 axis in CCR2-
DTR mice causes a rapid loss of intestinal m/ [53]. Furthermore,
intestinal CD64+ m/ derive almost exclusively from WT BM in
WT:CCR2/ mixed BM chimeric mice [8]. Steady state intestinal
m/ also do not divide in situ [7,54], indicating they unlikely to
self-renew and underlining the requirement for an external top-
up supply.
The cellular source of CCL2 which drives monocyte recruit-
ment is unknown, as are mechanisms responsible for its produc-
tion in the mucosa. Although exposure to the commensal
microbiota would seem an obvious candidate, studies of the size
of the intestinal m/ population in germ free mice have produced
conﬂicting results [17,55,56]. There have also been no direct stud-
ies of monocyte recruitment into the mucosa of GF or antibiotic
treated mice.
Finally, it is important to note that CCR2 may not be the only
recruitment mechanism, as intestinal m/ are not entirely absent
in steady state CCR2/ and CCL2/ mice [7,52]. Other mediators
which have been implicated by in vitro studies include TGFb and
IL8 [18,54], but the role of these and other mediators has not been
addressed in vivo. As noted above, it seems unlikely that the Ly6Clo
population of monocytes may be involved in the homeostasis of
intestinal m/. Although they can give rise to CD11c+ CX3CR1+ mye-
loid cells in Peyer’s patches (PP) [51], Ly6Clo monocytes have very
limited ability to enter non-lymphoid tissues and adoptive transfer
approaches have failed to ﬁnd them in recipient intestinal mucosa
[7,51]. Furthermore, intestinal m/ numbers appear to be normal in
CX3CR1-deﬁciecnt mice [26], which would not be anticipated if
Ly6Clo monocytes were involved, due to their dependence on the
CX3CL1-CX3CR1 axis for survival [57,58]. Nevertheless, given the
high expression of CX3CL1 by epithelial and goblet cells and the
apparent requirement for CX3CR1 in formation of transepithelial
dendrites by CX3CR1+ MPs [58], it remains possible that this che-
mokine pathway could be involved in localisation of intestinal
m/ towards the epithelial barrier after their arrival in the mucosa.
Together these ﬁndings indicate that the principal source of the
resident intestinal m/ pool is CCR2-dependent recruitment of
Ly6Chi monocytes. However whether m/ derived from primitive
progenitors also exist in the intestine alongside Ly6Chi monocyte-
derived m/ has never been formally tested.6. Monocyte differentiation in the steady state mucosa
As discussed above, Ly6Chi monocytes were originally referred
to as ‘inﬂammatory’ monocytes on the grounds that they migrated
efﬁciently into inﬂamed tissues. Together with the fact that Ly6Chi
monocytes respond vigorously to TLR ligation and other stimuli
in vitro [59], it was therefore initially surprising to ﬁnd that they
appeared to be the source of a profoundly anti-inﬂammatory pool
of m/. The explanation for this comes from experiments showing
that very soon after entry to the mucosa, Ly6Chi monocytes begin
to undergo a process of local differentiation that results in the gen-
eration of mature m/. This occurs via a series of short-lived
CX3CR1int intermediaries, which ﬁrst acquire MHCII before losing
Ly6C expression and upregulating F4/80, CD64 and CX3CR1 [7].
Within the space of 4–5 days, they have acquired the
F4/80hiCD64+MHCII+CD11c+CX3CR1hi phenotype typical of resi-
dent intestinal m/ [7]. The phenotypic differentiation continuum
of monocytes is paralleled by progressive acquisition of the typical
functions of resident intestinal m/, with increasing production of
IL10, enhanced phagocytic activity, acquisition of scavenger recep-
tors and the development of unresponsiveness to TLR ligation [7].
These processes appear to be unique to the intestine, as although
Ly6Chi monocytes enter other tissues such as the lung, they do
not undergo the same phenotypic changes [60]. Interestingly how-
ever, a similar developmental series of Ly6Chi monocytes has re-
cently been identiﬁed in skin [61], suggesting that the origins of
tissue m/ may need to be re-examined, especially those at body
surfaces where constant immune surveillance is needed.
The factors that inﬂuence monocyte differentiation in the intes-
tinal mucosa remain to be identiﬁed with certainty, and it is quite
likely that more than one factor may be needed to explain all as-
pects of the fully adapted proﬁle. The development of m/ in the
steady state gut mucosa is dependent on CSF1R, with essentially
all m/ being derived from WT BM in WT:CSF1R/ mixed BM chi-
meric mice [62] and their numbers are severely depleted by
administration of anti-CSF1R antibody in vivo [63]. Whether this
is due to the actions of CSF1 or IL34, the only other identiﬁed CSF1R
ligand, remains unclear. Although epidermal Langerhans cells and
microglia of the CNS have been shown to depend on the IL34-
CSF1R axis [64,65], the impact of IL34-deﬁciency on the intestinal
m/ compartment has never been examined directly. This CSF1R-
dependency contrasts with the resident m/ in some other tissues
that are derived from primitive precursors such as alveolar m/,
whose development is dependent on CSF2 [46,66]. However CSF1R
signalling alone is unlikely to account for all aspects of intestinal
m/ development, as it is required for the development of other
monocyte-derived m/ [62,63], whereas adoptively transferred
monocytes generate entirely distinctive m/ in the mucosa. Thus
the local environment of the intestinal mucosa must play a deﬁn-
itive role in local m/ development.
Most work on this topic has concentrated on the inability of
intestinal m/ to respond appropriately to inﬂammatory stimuli.
This is due at least in part to the constitutive production of high
levels of IL10 and colonic m/ from IL10-deﬁcient mice or mice
with LysM driven deletion of the IL10R signalling molecule STAT3
respond robustly to TLR stimulation with proinﬂammatory cyto-
kine production [17,55,67,68]. Moreover, spontaneous colitis
develops in mice in which the IL10-IL10R regulatory axis has been
disrupted [69,70] and IL10R deﬁciency leads to early onset, fulmin-
ant IBD in man [71]. Colitis development in the absence of IL10 sig-
nalling appears to be directly attributable to inappropriate m/
behaviour directed toward commensal bacteria, as rendering m/
unresponsive to TLR ligands through the deletion of the key TLR
adaptor molecule MyD88, prevents colitis development in the
IL10-deﬁcient mouse [68]. A role for IL10 in determining other
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explored, although it is known that the expression of the scavenger
receptor (CD163) and the mannose receptor may be under control
of IL10 [67].
TGFb is a further mediator that can reproduce the TLR hypore-
sponsiveness of mature intestinal m/ in monocytes or BM derived
m/ and in vivo, this could be derived from components of the
intestinal extracellular matrix or epithelial cells [18,72]. Although
TGFb has also been reported to induce CX3CR1 expression by
microglia in the brain [73], as yet there is no evidence that it can
account for the other features of resident intestinal m/ such as
IL10 production, MHCII expression or scavenger activity.
In addition to an effect on the recruitment of monocytes to the
mucosa, the microbiota may also inﬂuence their subsequent differ-
entiation, as m/ in the germ free intestine produce less IL10 [17].
There has been considerable interest in the idea that ligation of TLR
receptors by the microbiota could promote a feedback inhibition
pathway, similar to the well known phenomenon of ‘‘endotoxin
tolerance’’, in which exposure to a single TLR ligand such as LPS
prevents subsequent responses to the same agent. Whether this
accounts for the anti-inﬂammatory properties of resident intesti-
nal m/ is unclear, as is the nature of any TLR involved. For instance
the defective IL10 production seen in GF mice is not replicated in
MyD88/ mice [17], indicating some speciﬁcity to the phenome-
non. Notably, the hyporesponsiveness does not involve loss of
receptors such as TLR [7,18], although there may be downregula-
tion of associated adapter and signalling molecules such as CD14,
MyD88, TRAF-6, MD2, TRIF and IRAK1 [14,18,19]. In parallel, ma-
ture intestinal m/ upregulate mechanisms that interfere with
TLR signalling and/or NF-jB activation, including IRAK-M and
IkBNS [18,19,67]. Although some of these inhibitory processes
may be driven by IL10, other mechanisms are clearly involved. It
is also important to note that the hyporesponsiveness of intestinal
m/ does not just apply to TLR ligation, but affects reactivity to a
wide variety of stimuli including NOD ligands, intact bacteria,
phagocytosed particles and cIFN amongst others [14]. The role of
other pattern recognition receptors (PRR) in the effects of the mic-
robiota has not been investigated, and the full range of intestinal
m/ functions in GF mice is not known.
Despite high levels of CX3CR1 expression being one of the
most characteristic features of resident intestinal m/ and the fact
that its ligand CX3CL1 is produced by epithelial cells [58], the
exact role CX3CR1 plays in controlling m/ function is unclear.
The CX3CL1-CX3CR1 axis has been shown to control the ability
of CX3CR1+ MPs to sample luminal contents through the forma-
tion of transepithelial dendrites (TEDs) [58,74,75]. However the
physiological signiﬁcance of TED formation remains unclear, as
different groups have found them in different parts of the
intestine, and have reported them to be both TLR dependent
and independent [76]. Others have failed to ﬁnd them at all in
the steady state intestine [77].
As noted above, the CX3CL1-CX3CR1 axis appears to be required
for IL10 production by intestinal m/ [26], although the mecha-
nisms for this are unclear and other studies of CX3CR1 function
in intestinal m/ have produced conﬂicting results. For instance,
CX3CR1-deﬁcient mice have been shown both to be protected
[56,58] and more susceptible to experimental colitis [78]. Thus fur-
ther investigation of the CX3CR1-CX3CL1 axis is required to eluci-
date its involvement in the control of m/ function in the intestine.
The induction of MHCII on monocytes after their arrival in the
mucosa is a particularly intriguing and as yet, unexplained phe-
nomenon. It occurs normally in rag2/, IL10/ and cIFNR/
mice, eliminating many of the usual suspects for this phenomenon
such as lymphocytes and cIFN signalling (our unpublished obser-
vations). Extravasation of Ly6Chi monocytes through local vascular
endothelium has also been reported to induce upregulation ofMHCII by skin m/ [60], but this has not been explored with intes-
tinal m/.
Thus it is clear that multiple factors may inﬂuence monocyte
differentiation in the normal mucosa, acting in concert to ensure
that monocytes adapt to their unique immediate microenviron-
ment. However the nature and mechanisms of action of these
mediators remain to be deﬁned fully.7. Monocytes and macrophages in intestinal inﬂammation
The composition of the macrophage compartment in the intes-
tinal mucosa changes markedly when there is disruption of tissue
homeostasis by infection, inﬂammation or trauma. A variety of
experimental models has shown that this results in the accumula-
tion of monocytes and their proinﬂammatory mediators.
7.1. Sterile inﬂammation
During sterile intestinal inﬂammation, such as that induced by
feeding of DSS or transfer of naïve CD4+ T cells into lymphopenic
hosts, the normal balance between the proportions of CX3CR1hi
and CX3CR1int cells is reversed, with intense accumulation of
Ly6Chi monocytes and their immediate progeny [7]. In contrast,
the numbers of resident CX3CR1hi m/ change very little, because
unlike under steady state conditions, elicited monocytes do not
mature fully into anti-inﬂammatory CX3CR1hi m/. Instead they re-
main as CX3CR1int cells that retain their enhanced production of
proinﬂammatory cytokines (e.g. TNFa, IL6, IL12 and IL23), iNOS
and remain responsive to TLR stimulation [7,19,79]. Conversely,
the remaining resident CX3CR1hi m/ retain their anti-inﬂamma-
tory signature, despite the presence of active inﬂammation [7,19].
There are multiple lines of evidence to suggest that Ly6Chi
monocytes and their derivatives are directly pathogenic in chemi-
cally induced colitis. Firstly, monocytopenic CCR2-deﬁcient mice
are less susceptible to DSS-induced colitis [80]. Second, adminis-
tration of an anti-CCR2 depleting antibody, which is presumed to
target Ly6Chi monocytes selectively, ameliorates colitis and corre-
lates with lower levels of IL6 and IL1b in colonic tissue [19]. Finally,
DSS-induced colitis is severely reduced in mice in whom Ly6Chi
monocytes are deﬁcient in TNFa production [51]. As well as a
direct proinﬂammatory role, Ly6Chi monocytes and their progeny
may orchestrate the recruitment of other immune effector cells.
For instance, Ly6Chi monocyte-derived CCL11 is responsible for
the recruitment of CCR3+ eosinophils during DSS-induced colitis
[81]. Thus during sterile inﬂammation, Ly6Chi and their derivatives
appear to be overtly proinﬂammatory and as a result pathogenic.
Although most studies have focussed on the idea that the inﬁl-
tration of the mucosa by inﬂammatory cells is driven by CCR2
dependent recruitment of blood monocytes, recent work suggests
that intestinal neutrophils may also accumulate in T cell depen-
dent colitis via local differentiation of granulocyte-monocyte
progenitors present in the mucosa [82]. Whether this additional
mechanism could also apply to monocytes and m/ remains to be
examined.
7.2. Intestinal infection
CX3CR1int cells and Ly6Chi monocytes also accumulate in vast
numbers in the intestinal mucosa in response to pathogenic infec-
tions such as Toxoplasma gondii [83,84], Citrobacter rodentium [85]
and Salmonella typhimurium [12].
Oral inoculation of certain mouse strains with the protozoan
parasite T. gondii results in acute ileitis and the accumulation of
innate effector cells. Toxoplasmosis is lethal in CCR2- and CCL2-
deﬁcient mice and can be rescued by the adoptive transfer of
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role for Ly6Chi monocytes and their progeny. As in DSS colitis,
the Ly6Chi monocytes elicited by T. gondii infection produce the
proinﬂammatory cytokines TNFa and IL12, as well as reactive
nitrogen species [83]. Activation of monocytes in this infections
requires TLR-dependent recognition of PAMPs, as it is abrogated
in MyD88/ animals [86]. As well as being recruited by the classi-
cal CCL2-CCR2 axis, Ly6Chi monocytes can be attracted to the
T gondii infected mucosa in a CCR1-dependent manner by CCL3
derived from NKp46+ innate lymphoid cells (ILC) [84]. Manipula-
tion of the CCL3-CCR1 axis by gene deletion or antibody blockade
results in fewer inﬁltrating Ly6Chi monocytes and reduced inﬂam-
mation, but higher parasite burden, again supporting the idea that
these cells are directly involved in parasite clearance.
Infection with C. rodentium is used widely as a model of enter-
opathogenic and enterohaemorrhagic Escherichia coli infection in
man [85]. CCL2- and CCR2-deﬁcient mice show delayed clearance
of C. rodentium due to failure to recruit CD11b+ cells, implicating
Ly6Chi monocytes in the protective response [85]. It is believed that
CCL2 production by stromal cells following NOD2-dependent rec-
ognition of C. rodentium is the principal mechanism responsible
for the recruitment of CD11b+ cells to the colonic mucosa [85].
Interestingly however, DT-mediated ablation of the entire
monocyte/macrophage compartment using LysM-cre x CSF1R-
STOP-DTR mice does not alter the susceptibility to or ability to
clear C. rodentium infection [87]. In contrast, mice lacking migra-
tory DC due to deﬁciency in ﬂt3L or ablation of Zbtb46+ cells, suc-
cumb to lethal infection [10,87], consistent with the known role for
DC in driving protective Th17 responses against C. rodentium [85].
Thus monocytes/m/ contribute to, but are dispensable for immu-
nity towards C. rodentium.
Infection with Salmonella species has also demonstrated a role
for monocyte-derived cells in host protection. Infection of PP by
S. typhimurium results in the accumulation of highly bactericidal
Ly6Chi CD68+ MP that express iNOS and MHCII, and produce TNFa
[88]. Studies using mutant forms of S. typhimurim that lack a func-
tional type III secretion system (e.g. InvG), have shown that Salmo-
nella species can also enter the LP independently of PP [89]. This
‘alternative pathway’ relies on bacterial uptake by CD11c+CX3CR1+
MP in a MyD88-independent fashion [89]. More recent studies
have shown that uptake likely involves CX3CR1hi resident m/
and elicited CX3CR1int cells [12], many of which are likely to be
derivatives of Ly6Chi monocytes.
Although not yet studied in any detail, our own preliminary
experiments suggest that chronic infection with Helicobacter hepa-
ticus also leads to accumulation of Ly6Chi monocytes and CX3CR1int
early stage m/ which peaks at the same time as the protective
cIFN/IL17 T cell response [90] (and our unpublished observations).
Together these results underline the possible role of Ly6Chi mono-
cytes in protective immunity during intestinal infection with bac-
terial and intracellular pathogens.
Whether blood monocytes contribute at all to Th2-type immu-
nity and to the generation of the associated ‘‘alternatively acti-
vated’’ m/ is more questionable. Depletion of circulating
monocytes does not affect the numbers or activity of m/ during
pleural infection with the ﬁlarial nematode Litomosoides sigmon-
dontis [91]. Instead, a population of alternatively activated m/ ex-
pands through in situ self-renewal. However, genetic deletion of
CCL2 renders normally resistant C57Bl/6 mice susceptible to intes-
tinal Trichuris muris infection [92], the natural mouse model of hu-
man Trichuris trichura infection, one of the most prevalent
intestinal helminth infections. Similarly depletion of monocytes
and m/ by administration of clodronate liposomes leads to re-
duced clearance of Heligomosomoides polygyrus from the intestine
[93]. This discrepancy between intestinal and pulmonary helminth
infection could be consistent with the different origin of tissue m/in these tissues under normal conditions and further studies are re-
quired to fully elucidate the role of Ly6Chi monocytes during Th2
immunity.8. Monocytes/macrophages and adaptive immunity during
inﬂammation
Several reports have suggested that monocytes and their prog-
eny may accumulate in the draining MLN and contribute to the
generation of effector T cells there during intestinal inﬂammation
[8,19,94]. However the nature of the cells and how they get to
the MLN is controversial.
During DSS-induced colitis and T-cell transfer colitis, it has been
proposed that Ly6Chi monocytes can give rise to a population of DC
[17,19], which migrate from the mucosa to the MLN via afferent
lymphatics [19]. However other studies have challenged this con-
cept of monocyte-derived DC, by showing that Ly6Chi monocytes
in the mucosa give rise only to the m/ lineage even during overt
inﬂammation [7], and indicate that any monocyte-derived cells
that appear in the MLN arrive via the bloodstream. In support of
this idea, the Ly6Chi monocyte-derived MP that accumulate in
the MLN during T cell transfer colitis lack CCR7 [94] and this pro-
cess occurs in the absence of CCR7 [8]. Recently, it has been sug-
gested that some of the normally tissue resident CX3CR1hi m/ in
intestinal mucosa may acquire migratory capacity during infection
with S. typhimurium and may contribute to initiation of the speciﬁc
immune response in MLN [95]. However, with the discovery of
bona ﬁde CD103-CD11b+ DC that also express CX3CR1 at interme-
diate levels [7,9], the identity and origin of the CX3CR1+ MP that
capture and transport Salmonella to the MLN need to be clariﬁed.
It seems highly likely that Ly6Chi monocytes and their deriva-
tives may be able to interact with T cells in the inﬂamed mucosa
itself. Consistent with this idea, cells of the monocyte/m/ lineage
appear to be required to maintain IFNc-producing and IFNc+
IL17+ T cells in the mucosa during C. rodentium infection through
their local production of IL12 [87]. In addition, gut resident
CX3CR1hi macrophages that retain their anti-inﬂammatory proper-
ties during active colitis may act to suppress effector T cell prolif-
eration [96].9. A regulatory role for Ly6Chi monocytes?
Although Ly6Chi monocytes and their progeny have generally
been seen as proinﬂammatory effector cells, recent work has sug-
gested that they may have a dual role during T. gondii-induced
intestinal inﬂammation. Grainger and colleagues [97] have demon-
strated that as well as exhibiting potent parasite killing activity
and production of proinﬂammatory mediators, Ly6Chi monocytes
possess regulatory properties such as the production of IL10 and
expression of arginase. Moreover, these elicited Ly6Chi monocytes
can inhibit the pathogenic effects of neutrophils through COX-
2-dependent production of PGE2 [97]. Indeed this may explain
earlier observations of enhanced neutrophil accumulation in the
mucosa of T. gondii infected CCR2-deﬁcient animals [83]. Thus
Ly6Chi monocytes appear to be Janus-like, controlling both parasite
clearance and restoration of homeostasis by regulating the recruit-
ment and activity of other innate effector cells. Whether this regu-
latory role is speciﬁc to intestinal Ly6Chi monocytes in T. gondii
infection, or if these characteristics have been overlooked in other
models of infection and inﬂammation remains to be tested. For
example, although CD11b+ cells display both proinﬂammatory
(TNFa, iNOS, IL12p40) and regulatory characteristics (IL10, argi-
nase, Ym-1 expression) during C. rodentium infection [85], in this
instance resident m/ and elicited cells were analysed as a single
46 C.C. Bain, A.McI Mowat / Cellular Immunology 291 (2014) 41–48entity, making it unclear which characteristics belong to which
population.10. Monocytes/macrophages during resolution of inﬂammation
The composition of the m/ pool also changes markedly during
the resolution of intestinal inﬂammation. In mice, the CX3CR1int
compartment contracts to homeostatic levels, which is paralleled
by a contraction in neutrophil numbers [19]. Whether any elicited
Ly6Chi monocytes persist and convert into anti-inﬂammatory
CX3CR1hi m/, or if they are cleared through local apoptosis as in
other tissues [98] remains unclear. Importantly, the contribution
of intestinal m/ to the restoration of homeostasis is dependent
on the TGFbTGFbR axis, as there is delayed resolution of DSS-
induced colitis when m/ are unresponsive to TGFb [13]. In view
of the potential importance of understanding the mechanisms of
tissue repair and healing for treating chronic inﬂammatory disease,
more studies are warranted on how m/ can adapt to different
conditions.11. Monocytes in human gut
Consistent with mouse studies, m/ are one of the most abun-
dant leucocytes in the human intestinal mucosa, where they accu-
mulate close to the epithelial layer [7]. Although often identiﬁed by
their expression of CD33 and CD13 [4,99,100], recent studies have
shown that there is sufﬁcient conservation of surface marker
expression between mouse and man to allow more direct compar-
isons to be made. Thus m/ dominating the healthy human ileal
mucosa express CD64, MHCII and the scavenger receptor CD163
[7], as well as CD68 and CD14 [4,7,18]. Whereas resident m/ ex-
press low levels of CD14, a smaller population of CD14hi m/ is also
present in the healthy mucosa [7]. These CD14hi cells are heteroge-
neous for expression of MHCII, CD163 and CD209, as well as
CD11c, suggesting that they may represent recent CD14hi mono-
cyte emigrants, akin to the continuum of CX3CR1int cells seen in
the mouse intestine [7]. Interestingly, m/ resident in the human
small intestine uniformly express high levels of MHCII [14],
whereas those in the colonic mucosa have been suggested to ex-
press low levels of MHCII [4]. This dichotomy is not seen in mouse
and thus the anatomical location of m/ may impact upon their
phenotype selectively in humans.
During intestinal inﬂammation such as that associated with
Crohn’s disease and ulcerative colitis, CD14hi monocyte-derived
cells have been shown to accumulate [7,99,101,102]. These re-
cruited CD14hi cells display enhanced production of TNFa, IL1b
and IL6 [102] and respiratory burst activity [15], as well as respon-
siveness to exogenous stimulation by e.g. TLR ligands [99,101].
However recruited monocytes may behave differently in CD com-
pared with UC, for instance only those in the CD inﬂamed mucosa
produce IL23, consistent with Th1/Th17 skewing in this condition
[98,99]. Elegant studies using transfer of radiolabelled autologous
blood monocytes have demonstrated that these CD14hi monocytes
derive from circulating monocytes rather than proliferation of gut
resident cells [103], while elevated levels of the monocyte chemo-
attractants CCL2 and CCL4 are found in the mucosa of IBD patients
[104]. Similar to Ly6Chi monocytes inﬁltrating the inﬂamed mouse
mucosa, CD14hi monocyte/macrophages in the UC inﬂamed muco-
sa have been shown to produce chemokines to attract other effec-
tor leucocytes, such as eosinophils through their production of
CCL11 [100]. Whether these inﬁltrating CD14hi cells exhibit also
exhibit regulatory characteristics remains to be explored. Thus
the behaviour of monocytes and m/ in human and mouse intestine
seems to follow analogous processes in both steady state and ininﬂammation, suggesting animal models remain a valuable means
of exploring these processes.
12. Concluding remarks
Much progress has been made recently into understanding the
role of m/ in the intestine under physiological conditions, as well
as when the steady state is disrupted by inﬂammation and/or
infection. In both settings, m/ of the gut wall derive from blood
monocytes that enter the mucosa and mature locally, with their
fate dictated by the cues received from their immediate environ-
ment. Thus future work must set out to identify the factors that
promote or disrupt monocyte differentiation as these may hold
promise as new therapeutic targets for the treatment of IBD.
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